Table 7 Outcome table for function

Bateman et al. (2014) [38]

I: 4

C1: 4

(concentric group)

C2:3

(no exercise)

I: 1

C1: 1

C2: 0

Oxford Shoulder Score

Baseline: 34.0 (SD 5.3)

Post-treatment (8 weeks): 31.3 (SD 6.3)

Δ − 2.7

Oxford Shoulder Score

Baseline: 24.0 (SD 3.7)

Post-treatment (8 weeks): 24.3 (SD 4.2)

Δ + 0.3

Control group 2 (C2) excluded because no treatment was given.

Function measured with the 12-item Oxford Shoulder Score. Range 12–60, where 12 indicates no pain and normal function and higher is worse. MID 6 points [43].

Blume et al. (2015) [35]

I: 18

C: 20

I: 0

C: 4

DASH

Baseline: 25.0 (SD 10.6)

Post-treatment (8 weeks): 12.1 (SD 11.7)

Δ − 12.9

DASH

Baseline: 21.2 (SD 6.5)

Post-treatment (8 weeks): 9.3 (SD 7.1)

Δ − 11.9

Function measured with the 30-item DASH questionnaire. Range 0–150, higher is worse. MID = 10.5 points [40].

Chaconas et al. (2017) [34]

I: 25

C: 21

I: 0

C: 2

WORC

Baseline: 66.6 (SD 16.0)

Post-treatment (6 weeks): 87.6 (SD 14.5)

Δ + 21.0

At 6 months: 92.7 (SD 9.0)

Δ + 26.1

WORC

Baseline: 65.4 (SD 14.1)

Post-treatment (6 weeks): 70.6 (SD 16.8)

Δ + 5.2

At 6 months: 77.2 (SD 15.9)

Δ + 11.8

Function measured with WORC. Total range 0–2100 (aggregate score of 6 total sub-domains), here reported as scores out of 100 i.e. a percentage of normal score, where higher is better. MID = 275 points [39].

Dejaco et al. (2017) [37]

I: 20

C: 16

I: 1

C: 1

Constant-Murley Score

Baseline: 72.5 (SD 17.7)

Post-treatment (12 weeks): 87.3 (SD 16.2)

Δ + 14.8

At 6 months: 86.9 (SD 16.8)

Δ + 14.4

Constant-Murley Score

Baseline: 78.9 (SD 8.5)

Post-treatment (12 weeks): 87.6 (SD 7.8)

Δ + 8.7

At 6 months: 88.8 (SD 8.1)

Δ + 9.9

Function measured with Constant-Murley Score. Four subscales (pain, ADL, ROM, strength). Total range 0–100, where 100 indicates excellent shoulder function. MID = 17 points [41].

Hallgren et al. (2014) [50]

I: 51

C: 46

I: 1

C:1

Constant-Murley Score

Baseline: 48.5 (SD 15.0)

1-year follow up: 83.0 (SD 14.0)

Δ + 34.5

Constant-Murley Score

Baseline: 43.5 (SD 15.0)

1-year follow up: 76.0 (SD 18.0)

Δ + 32.5

Long-term follow-up of the study by Holmgren et al. 2012.

Baseline values from the Holmgren et al. paper.

Holmgren et al. (2012) [26]

I: 51

C: 46

I: 0

C: 0

Constant-Murley Score

Baseline: 48.5 (SD 15.0)

Post-treatment (12 weeks): 72.5 (SD 19.0)

Δ + 24

Constant-Murley Score

Baseline: 43.5 (SD 15.0)

Post-treatment (12 weeks): 52.5 (SD 23.0)

Δ + 9

Maenhout et al. (2013) [25]

I: 31

C: 30

I: 4

C: 5

SPADI

Baseline: 42.0 (SD 11.0)

Post-treatment (12 weeks): 17.0 (SD 11.4)

Δ −25.7

SPADI

Baseline: 44.3 (SD 11.5)

Post-treatment (12 weeks): 14.5 (SD 11.7)

Δ − 27.0

Measured with SPADI. A 13-item scale (5 items on pain, 8 on disability). Range 0–130, higher is worse. Pain and disability subscales not reported separately. MID = 18 points [40].

Vallés-Carrascosa et al. (2018) [32]

I: 11

C: 11

I: 0

C: 0

Constant-Murley Score

Baseline: 35.0 (22.0; 47.0)

Post-treatment (4 weeks): 59.0 (50.0; 68.0)

Δ + 24.0

Constant-Murley Score

Baseline: 36.0 (22.0; 45.0)

Post-treatment (4 weeks): 65.0 (55.0; 69.0)

Δ + 29.0

Median (1st;3rd quartile)